$8.40 2.5%
MNMD Stock Price vs. AI Score
Data gathered: November 13

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Mind Medicine (MindMed)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.


Mind Medicine (MindMed)
Price $8.40
Target Price Sign up
Volume 1,410,000
Market Cap $658M
Year Range $5.17 - $11.75
Dividend Yield 0%
Analyst Rating 100% buy
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2407.6M-7.6M-14M-25M0.000
Q2 '242.5M9.8M-7.3M-5.9M-24M-0.260
Q1 '24011M-12M-54M-22M-1.140
Q4 '231.3M11M-10M-24M-21M-0.590
Q3 '23670,0009.2M-8.5M-18M-21M-0.450

Insider Transactions View All

Sullivan Mark filed to sell 177,716 shares at $6.
September 25 '24
Karlin Dan filed to sell 344,656 shares at $6.
September 25 '24
Liao Carrie filed to sell 99,543 shares at $6.
September 25 '24
Barrow Robert filed to sell 545,772 shares at $6.
September 25 '24
GRYSKA DAVID W filed to buy 17,351 shares at $6.
August 26 '24

What is the Market Cap of Mind Medicine (MindMed)?

The Market Cap of Mind Medicine (MindMed) is $658M.

What is the current stock price of Mind Medicine (MindMed)?

Currently, the price of one share of Mind Medicine (MindMed) stock is $8.40.

How can I analyze the MNMD stock price chart for investment decisions?

The MNMD stock price chart above provides a comprehensive visual representation of Mind Medicine (MindMed)'s stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Mind Medicine (MindMed) shares. Our platform offers an up-to-date MNMD stock price chart, along with technical data analysis and alternative data insights.

Does MNMD offer dividends to its shareholders?

As of our latest update, Mind Medicine (MindMed) (MNMD) does not offer dividends to its shareholders. Investors interested in Mind Medicine (MindMed) should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Mind Medicine (MindMed)?

Some of the similar stocks of Mind Medicine (MindMed) are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.